81 related articles for article (PubMed ID: 9020529)
1. The effect of pentagastrin, cholecystokinin and their analogues on rat arterial blood pressure and isolated heart.
Wiśniewska R; Wiśniewski K
Rocz Akad Med Bialymst; 1996; 41(2):183-90. PubMed ID: 9020529
[TBL] [Abstract][Full Text] [Related]
2. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
[TBL] [Abstract][Full Text] [Related]
3. Effects of cholecystokinin, caerulein and pentagastrin on arterial blood pressure and plasma renin activity in rats.
Wiśniewska RJ
Pol J Pharmacol; 1997; 49(6):419-23. PubMed ID: 9566045
[TBL] [Abstract][Full Text] [Related]
4. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
[TBL] [Abstract][Full Text] [Related]
5. The influence of C-terminal cholecystokinin fragments in the circulatory system of rats.
Wiśniewska RJ; Kupryszewski G
Pol J Pharmacol Pharm; 1992; 44(3):281-7. PubMed ID: 1470565
[TBL] [Abstract][Full Text] [Related]
6. The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):573-83. PubMed ID: 2577226
[TBL] [Abstract][Full Text] [Related]
7. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
8. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
[TBL] [Abstract][Full Text] [Related]
9. The influence of SPC-703 on blood pressure in rabbits and rats and on isolated heart of guinea pigs.
Matuszek M; Gagało I; Hać E
Pol J Pharmacol Pharm; 1979; 31(5):455-9. PubMed ID: 547276
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
Fossa AA; DePasquale MJ; Morrone J; Zorn SH; Bryce D; Lowe JA; McLean S
J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of secretin in intact rats versus rats with streptozotocin-induced diabetes mellitus.
Sitniewska E; Wiśniewska RJ
Pol J Pharmacol; 1999; 51(2):131-6. PubMed ID: 10425641
[TBL] [Abstract][Full Text] [Related]
12. Effects of prolonged cholecystokinin administration on rat pituitary-adrenocortical axis: role of the CCK receptor subtypes 1 and 2.
Malendowicz LK; Spinazzi R; Majchrzak M; Nowak M; Nussdorfer GG; Ziolkowska A; Macchi C; Trejter M
Int J Mol Med; 2003 Dec; 12(6):903-9. PubMed ID: 14612964
[TBL] [Abstract][Full Text] [Related]
13. The effect of cholecystokinin (CCK-33) and C-terminal fragments of cholecystokinin: CCK-8 and CCK-4 on the cardiovascular system in rats.
Wiśniewska RJ; Wiśniewski K
Gen Pharmacol; 1996 Jan; 27(1):159-63. PubMed ID: 8742514
[TBL] [Abstract][Full Text] [Related]
14. Influence of nitric oxide on the cardiovascular action of secretin in intact rats. Part B. Does nitric oxide influence the effect of secretin on isolated heart function?
Sitniewska EM; Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 2000; 52(5):375-81. PubMed ID: 11334230
[TBL] [Abstract][Full Text] [Related]
15. Study of the in vivo and in vitro cardiovascular effects of a hydralazine-like vasodilator agent (HPS-10) in normotensive rats.
Orallo F
Br J Pharmacol; 1997 Aug; 121(8):1627-36. PubMed ID: 9283696
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and respiratory responses to a panicogenic agent in anaesthetised female Wistar rats at different stages of the oestrous cycle.
Brack KE; Jeffery SM; Lovick TA
Eur J Neurosci; 2006 Jun; 23(12):3309-18. PubMed ID: 16820020
[TBL] [Abstract][Full Text] [Related]
17. Subendocardial and subepicardial pressure-flow relations in the rat heart in diastolic and systolic arrest.
Lamberts RR; Willemsen MJ; Sipkema P; Westerhof N
J Biomech; 2004 May; 37(5):697-707. PubMed ID: 15046999
[TBL] [Abstract][Full Text] [Related]
18. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
19. Effect of central and peripheral administrations of cholecystokinin-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat.
Mongeau R; Marsden CA
Biol Psychiatry; 1997 Sep; 42(5):335-44. PubMed ID: 9276073
[TBL] [Abstract][Full Text] [Related]
20. Hypotensive effect of aqueous extract of the leaves of Phyllanthus amarus Schum and Thonn (Euphorbiaceae).
Amaechina FC; Omogbai EK
Acta Pol Pharm; 2007; 64(6):547-52. PubMed ID: 18323250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
